The company is guiding to a revenue range of $22.5 million to $24.5 million for Q4 2025, with Frost noting, "The lower end of the range reflects the potential risk of a prolonged U.S. government ...
HOLLISTON, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (HBIO) will announce its financial results for the quarter ended June 30, 2025, before the market opens on August 11, 2025, ...
Harvard Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.025. Operator: Good day, and welcome to the Second Quarter 2025 Harvard Bioscience Earnings ...
Holliston biotechnology firm Harvard Bioscience continued its fourth quarter momentum with revenue up 14% in the first quarter of 2021 when compared to the first quarter of 2020. Holliston ...
The MarketWatch News Department was not involved in the creation of this content. HOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the "Company" or ...
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Completes Repayment of Existing Credit Agreement, Extends Debt Maturity, and Enhances Financial Flexibility BroadOak Partner Bill Snider to Join Board of Directors and Company to Form Advisory Board ...
HOLLISTON, Mass. (AP) — HOLLISTON, Mass. (AP) — Harvard Bioscience Inc. (HBIO) on Monday reported a loss of $2.3 million in its second quarter. The Holliston, Massachusetts-based company said it had a ...
(RTTNews) - Harvard Bioscience, Inc. (HBIO), a maker of life sciences equipment to support research and drug discovery, said on Thursday that it has appointed John Duke as Chief Executive Officer to ...
HOLLISTON, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (HBIO) will announce its financial results for the quarter ended September 30, 2025, before the market opens on November 6, ...
Operator: Good day, and welcome to the Third Quarter 2025 Harvard Bioscience Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the ...
Jim Green will retire from his roles as chairman, president, and CEO of Harvard Bioscience on July 28. Harvard Bioscience falls out of Nasdaq compliance after board member resignation Harvard ...